• 1
    “A Metal-Based Inhibitor of Tumor Necrosis Factor-α”: Angew. Chem.­ 2012, 124, 9144–9148; Angew. Chem. Int. Ed­ 2012, 51, 9010–9014. (The first iridium(III) complex ([Ir(ppy)2(biq)]+) that targets the tumor necrosis factor-α (TNF-α) protein-protein interface.)
  • 2
    “Structure-Based Discovery of Natural Product-Like TNF-α Inhibitors”: Angew. Chem.­ 2010, 122, 2922–2926; Angew. Chem. Int. Ed.­ 2010, 49, 2860–2864. (Two natural-product-like inhibitors were discovered that represented, at the time, only the third and fourth examples of the direct targeting of TNF-α by a small molecule.)
  • 3
    “Platinum(II) Complexes with Dipyridophenazine Ligands as Human Telomerase Inhibitors and Luminescent Probes for G-Quadruplex DNA”: J. Am. Chem. Soc­ 2009, 131, 1835–1846. (First example of the use of platinum(II) complexes as G-quadruplex DNA-binding luminescent probes and human telomerase inhibitors.)